Cyclooxygenase-2—10 Years Later

Appleby, 1994, Structure of the human cyclo-oxygenase-2 gene., Biochem J, 302, 723, 10.1042/bj3020723

Baba, 2001, Direct activation of rat spinal dorsal horn neurons by prostaglandin E2., J Neurosci, 21, 1750, 10.1523/JNEUROSCI.21-05-01750.2001

Beiche, 1996, Upregulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation., FEBS Lett, 390, 165, 10.1016/0014-5793(96)00604-7

Bombardier, 2000, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group, N Engl J Med, 343, 1520, 10.1056/NEJM200011233432103

Brater, 2001, Renal effects of COX-2-selective inhibitors., Am J Nephrol, 21, 1, 10.1159/000046212

Brune K Zeilhofer HU Hinz B (1999) Cyclo-oxygenase inhibitors: new insights. in Fast Facts—Rheumatology Highlights 1998–99, ed Emery P (Health Press, Oxford, UK), pp 18–24.

Catella-Lawson, 1999, Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids., J Pharmacol Exp Ther, 289, 735

Chakraborty, 1996, Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids., J Mol Endocrinol, 16, 107, 10.1677/jme.0.0160107

Crofford, 2000, Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases., Arthritis Rheum, 43, 1891, 10.1002/1529-0131(200008)43:8<1891::AID-ANR28>3.0.CO;2-R

Damm, 2001, Constitutive expression and localization of COX-1 and COX-2 in rabbit iris and ciliary body., Exp Eye Res, 72, 611, 10.1006/exer.2001.0977

Davis, 1999, Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1β., Endocrinology, 140, 2685, 10.1210/endo.140.6.6715

Dixon, 2000, Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region., J Biol Chem, 275, 11750, 10.1074/jbc.275.16.11750

Ehrich, 1999, Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model., Clin Pharmacol Ther, 65, 336, 10.1016/S0009-9236(99)70113-X

Ehrich, 1999, Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6-week double-blind, placebo-controlled, pilot study of rofecoxib., J Rheumatol, 26, 2438

Fitzgerald, 2000, Cyclo-oxygenase products and atherothrombosis., Ann Med, 32 (Suppl 1), 21

Förstermann U (1996) Pharmakologie des kardiovaskulären Systems: die Blutgefäße. in Allgemeine und Spezielle Pharmakologie und Toxikologie, eds Forth W Henschler D Rummel W Starke K (Spektrum Akademischer Verlag, Heidelberg, Berlin, Oxford), pp 407–435.

Fu, 1990, The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes., J Biol Chem, 265, 16737, 10.1016/S0021-9258(17)44821-6

Fu, 1999, Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis., Gastroenterology, 116, 1319, 10.1016/S0016-5085(99)70496-8

Gibb, 1996, Localization of prostaglandin H synthase type 2 protein and mRNA in term human fetal membranes and decidua., J Endocrinol, 150, 497, 10.1677/joe.0.1500497

Harris, 2000, Interactions of the renin-angiotensin system and neuronal nitric oxide synthase in regulation of cyclooxygenase-2 in the macula densa., Acta Physiol Scand, 168, 47, 10.1046/j.1365-201x.2000.00642.x

Harris, 1994, Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction., J Clin Invest, 94, 2504, 10.1172/JCI117620

Hinz, 2000, Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E2 and nonsteroidal anti-inflammatory drugs., Biochem Biophys Res Commun, 278, 790, 10.1006/bbrc.2000.3885

Hinz, 2000, Prostaglandin E2 up-regulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages., Biochem Biophys Res Commun, 272, 744, 10.1006/bbrc.2000.2859

Hinz B Dorn CP Shen TY Brune K (2000c) Anti-inflammatory—Antirheumatic Drugs. Ullmann's Encyclopedia of Industrial Chemistry Sixth Edition, 2000 Electronic Release (Wiley-VCH, Weinheim).

Hinz, 2000, Salicylate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E2 synthesis in murine macrophages., Biochem Biophys Res Commun, 274, 197, 10.1006/bbrc.2000.3123

Iseki, 1995, Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach., Histochem J, 27, 323, 10.1007/BF00398975

Jones, 1999, Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing., Nat Med, 5, 1418, 10.1038/70995

Kalgutkar, 1998, Aspirin-like molecules that covalently inactivate cyclooxygenase-2., Science (Wash DC), 280, 1268, 10.1126/science.280.5367.1268

Kalgutkar, 2000, Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal anti-inflammatory drugs to potent and highly selective COX-2 inhibitors., Proc Natl Acad Sci USA, 97, 925, 10.1073/pnas.97.2.925

Kawamori, 1998, Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis., Cancer Res, 58, 409

Komhoff, 2000, Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development., Kidney Int, 57, 414, 10.1016/S0085-2538(15)46757-2

Kopp, 1994, Inhibition of NF-κB by sodium salicylate and aspirin., Science (Wash DC), 265, 956, 10.1126/science.8052854

Kraemer, 1992, Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5′-flanking regulatory sequences., Arch Biochem Biophys, 293, 391, 10.1016/0003-9861(92)90411-O

Kurumbail, 1996, Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents., Nature (Lond), 384, 644, 10.1038/384644a0

Langenbach, 1999, Cycloocygenase knockout mice. Models for elucidating isoform-specific functions., Biochem Pharmacol, 58, 1237, 10.1016/S0006-2952(99)00158-6

Langman, 1999, Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs., J Am Med Assoc, 282, 1929, 10.1001/jama.282.20.1929

Lee, 1992, Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide., J Biol Chem, 267, 25934, 10.1016/S0021-9258(18)35698-9

Leese, 2000, Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial., J Clin Pharmacol, 40, 124, 10.1177/00912700022008766

Lefkowith, 1999, Cyclooxygenase-2 specificity and its clinical implications., Am J Med, 106, 43S, 10.1016/S0002-9343(99)00116-3

Loftin, 2001, Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2., Proc Natl Acad Sci USA, 98, 1059, 10.1073/pnas.98.3.1059

Luong, 1996, Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2., Nature Struct Biol, 3, 927, 10.1038/nsb1196-927

Maihöfner, 2001, Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes., Invest Ophthalmol Vis Sci, 42, 2616

Maldve, 2000, Prostaglandin E2 regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors., J Lipid Res, 41, 873, 10.1016/S0022-2275(20)32029-0

Marnett, 1999, Cyclooxygenase inhibitors: discovery, selectivity and the future., Trends Pharmacol Sci, 20, 465, 10.1016/S0165-6147(99)01385-1

McAdam, 1999, Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2., Proc Natl Acad Sci USA, 96, 272, 10.1073/pnas.96.1.272

McCarthy, 1999, Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection., Am J Gastroenterol, 94, 1218, 10.1111/j.1572-0241.1999.01070.x

Minghetti, 1997, Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs., Eur J Neurosci, 9, 934, 10.1111/j.1460-9568.1997.tb01444.x

Mizuno, 1997, Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice., Gastroenterology, 112, 387, 10.1053/gast.1997.v112.pm9024292

Nantel, 1999, Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation., Br J Pharmacol, 128, 853, 10.1038/sj.bjp.0702866

Nantel, 1999, Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly., FEBS Lett, 457, 475, 10.1016/S0014-5793(99)01088-1

Niiro, 1997, Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils., Blood, 89, 1621, 10.1182/blood.V89.5.1621

Onoe, 1996, IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts., J Immunol, 156, 758, 10.4049/jimmunol.156.2.758

Pasinetti, 2001, Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia., Arch Gerontol Geriatr, 33, 13, 10.1016/S0167-4943(01)00091-7

Patrignani, 1997, Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs., J Physiol Pharmacol, 48, 623

Pratico, 2001, Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice., Proc Natl Acad Sci USA, 98, 3358, 10.1073/pnas.061607398

Prescott SM Fitzpatrick FA (2000) Cyclooxygenase-2 and carcinogenesis Biochim Biophys Acta 1470:M69–M78.

Preston, 1989, Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis., Br J Clin Pharmacol, 27, 607, 10.1111/j.1365-2125.1989.tb03423.x

Riendeau, 2001, Etoricoxib (MK-0663) preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2., J Pharmacol Exp Ther, 296, 558

Rossat, 1999, Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects., Clin Pharmacol Ther, 66, 76, 10.1016/S0009-9236(99)70056-1

Samad, 2001, Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity., Nature (Lond), 410, 471, 10.1038/35068566

Sawdy, 2000, The roles of the cyclo-oxygenases types one and two in prostaglandin synthesis in human fetal membranes at term., Placenta, 21, 54, 10.1053/plac.1999.0438

Schmassmann, 1998, Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats., Br J Pharmacol, 123, 795, 10.1038/sj.bjp.0701672

Silverstein, 2000, Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study., J Am Med Assoc, 284, 1247, 10.1001/jama.284.10.1247

Slater, 1999, Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy., Mol Hum Reprod, 5, 880, 10.1093/molehr/5.9.880

Slater, 1999, Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy., J Mol Endocrinol, 22, 125, 10.1677/jme.0.0220125

Smith, 1998, Pharmacological analysis of cyclooxygenase-1 in inflammation., Proc Natl Acad Sci USA, 95, 13313, 10.1073/pnas.95.22.13313

Stewart, 1997, Risk of Alzheimer's disease and duration of NSAID use., Neurology, 48, 626, 10.1212/WNL.48.3.626

Topper, 1996, Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress., Proc Natl Acad Sci USA, 93, 10417, 10.1073/pnas.93.19.10417

Traynor, 1999, Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2., Am J Physiol, 277, F706

Tsujii, 1998, Cyclooxygenase regulates angiogenesis induced by colon cancer cells., Cell, 93, 705, 10.1016/S0092-8674(00)81433-6

Vane, 1971, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs., Nat New Biol, 231, 232, 10.1038/newbio231232a0

Whelton, 2000, Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor., Am J Ther, 7, 159, 10.1097/00045391-200007030-00004

Whittle, 1980, Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa., Nature (Lond), 284, 271, 10.1038/284271a0

Xie, 1991, Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing., Proc Natl Acad Sci USA, 88, 2692, 10.1073/pnas.88.7.2692

Xu, 1999, Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate., Proc Natl Acad Sci USA, 96, 5292, 10.1073/pnas.96.9.5292

Zembowicz, 1995, Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine., J Clin Invest, 96, 1688, 10.1172/JCI118211

Zhang, 1999, Regulation of cyclooxygenase-2 (COX-2) in rat renal cortex by adrenal glucocorticoids and mineralocorticoids., Proc Natl Acad Sci USA, 96, 15280, 10.1073/pnas.96.26.15280

Zimmermann, 1998, Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa., Mol Pharmacol, 54, 536, 10.1124/mol.54.3.536